Answers are grounded in this paper and cite their sources.
Demonstrates improved antimicrobial properties of a Ru(III) complex compared to its Schiff base ligand, suggesting potential applications.
This study highlights the synthesis and characterization of a tetradentate ONNO Schiff base ligand named (Bis[3-methoxysalicylydene]-4-chloro-1,2-diimino-phenylenediamine), and thereafter complexing with Ru(III). The Schiff base ligand was synthesized from o-Vanillin and 4-Chloro-o-phenylenediamine in a 2:1 molar ratio. The ligand and the complex were characterized by elemental analysis, FTIR, UV, ¹H NMR, and ¹³C NMR spectroscopy. The Schiff base ligand and complexes have been screened for antimicrobial property against CPE (Clostridium perfringens enterotoxin) (PDB ID:2XH6) by molecular docking. It has been observed that the affinity of the complex is greater than the ligand.
No takes yet. Share an insight, caveat, or question.
Manju Yadav (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: